Adverum Biotechnologies's total assets for Q2 2025 were $96.18M, a decrease of -30.13% from the previous quarter. ADVM total liabilities were $116.40M for the fiscal quarter, a 4.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.